Le dernier exercice comptable publié pour cette entreprise remonte à 2018. Les données ci-dessous peuvent ne plus refléter sa situation actuelle.
MON BIO : revenue, balance sheet and financial ratios
MON BIO is a French company
founded 11 years ago,
specialized in the sector Autres commerces de détail alimentaires en magasin spécialisé .
Based in VOIRON (38500),
this company of category PME
shows in 2018 a revenue of 1.8 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-08-08
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
Synthèse
Santé financière :
Fragile
Signal structurel : résultat d'exploitation insuffisant pour couvrir les intérêts.
In summary, MON BIO posts positive profitability over the latest financial year. Its financial structure is fragile, with debt above sector norms — a point to monitor.
Revenue and income statement
In 2025, MON BIO generates positive net income of 14 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Revenue (2018)
?
1 819 739 €
Gross margin (2018)
?
529 974 €
Net income (2018)
?
54 136 €
EBITDA margin (2018)
?
3.9%
Loading income statement...
The detailed income statement is not available for this company (simplified accounts or confidential data).
Assets
Loading data...
Assets balance sheet data not available for this company
Liabilities
Loading data...
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 91%. This ratio is less favorable than the sector median (17.2%) and warrants attention. Financial autonomy (= Equity / Total assets x 100) reaches 41%. This ratio is slightly less favorable than the sector median (41.5%). Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 3.1 years of cash flow to repay all financial debt. This ratio remains within usual banking standards. Cash flow represents 3.6% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.
Debt ratio (2018)
?
90.99%
Financial autonomy (2018)
?
40.75%
Cash flow / Revenue (2018)
?
3.62%
Repayment capacity (2018)
?
3.15
Asset age ratio (2018)
?
51.7%
| Indicator |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
2025 |
| Debt ratio |
165.973 |
103.896 |
90.99 |
346.949 |
241.675 |
227.308 |
235.105 |
179.676 |
146.734 |
118.38 |
| Financial autonomy |
26.089 |
36.52 |
40.747 |
16.995 |
22.628 |
23.207 |
23.323 |
27.641 |
30.236 |
32.813 |
| Repayment capacity |
2.437 |
2.572 |
3.153 |
None |
None |
None |
None |
None |
None |
None |
| Cash flow / Revenue |
4.375% |
3.536% |
3.616% |
None% |
None% |
None% |
None% |
None% |
None% |
None% |
Sector positioning
Q1: 1.86%
Med: 17.22%
Q3: 50.64%
Watch
In 2025, the debt ratio of MON BIO (118.4%) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.
Q1: 15.39%
Med: 41.51%
Q3: 61.41%
Average
In 2025, the financial autonomy of MON BIO (32.8%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 2.94. This ratio is slightly less favorable than the sector median (1.8). The interest coverage ratio (= EBIT / Interest expenses) is 0.6x. Danger: operating income does not cover interest charges, unsustainable situation.
Liquidity ratio (2018)
?
2.94
Interest coverage (2018)
?
0.56
| Indicator |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
2025 |
| Liquidity ratio |
2.09352 |
2.64175 |
2.94 |
1.6625899999999998 |
1.89855 |
1.77243 |
1.92494 |
2.11869 |
1.9564 |
1.6151900000000001 |
| Interest coverage |
0.583 |
0.612 |
0.563 |
None |
None |
None |
None |
None |
None |
None |
Sector positioning
Q1: 1.11
Med: 1.79
Q3: 2.8
Average
-18 pts over 3 years
In 2025, the liquidity ratio of MON BIO (1.62) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Overall, WCR represents 36 days of revenue, i.e. 0 € to permanently finance. Between 2016 and 2018, WCR worsened by 17 days of revenue, signaling an increased financing need.
Operating WCR (2018)
?
182 520 €
Customer credit (2018)
?
0 j
Supplier credit (2018)
?
23 j
Inventory turnover (2018)
?
27 j
WCR in days of revenue (2018)
?
36 j
| Indicator |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
2025 |
| Operating WCR |
96 517 € |
122 634 € |
182 520 € |
0 € |
0 € |
0 € |
0 € |
0 € |
0 € |
0 € |
| Inventory turnover (days) |
25 |
22 |
27 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Customer payment term (days) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Supplier payment term (days) |
18 |
17 |
23 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Positioning of MON BIO in its sector
Valuation estimate
Based on 300 transactions of similar company sales
(all years),
the value of MON BIO is estimated at
72 752 €
(range 34 415€ - 150 720€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
72 752 €
Range: 34 415€ - 150 720€
NAF 5 all-time
Valuation method used
Net Income Multiple
14 151 €
×
5.1x
=
72 753 €
Range: 34 415€ - 150 721€
Only this financial indicator is available for this company.
How is this estimate calculated?
This estimate is based on the analysis of 300 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
- EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
- Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
- Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Top companies in Autres commerces de détail alimentaires en magasin spécialisé
Largest companies by revenue in the sector Autres commerces de détail alimentaires en magasin spécialisé :
Frequently asked questions about MON BIO
What is the revenue of MON BIO ?
The revenue of MON BIO in 2018 is 1.8 M€.
Is MON BIO profitable?
Yes, MON BIO generated a net profit of 14 k€ in 2025.
Where is the headquarters of MON BIO ?
The headquarters of MON BIO is located in VOIRON (38500), in the department Isere.
Where to find the tax return of MON BIO ?
The tax return of MON BIO is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does MON BIO operate?
MON BIO operates in the sector Autres commerces de détail alimentaires en magasin spécialisé (NAF code 47.29Z). See the 'Sector positioning' section above to compare the company with its competitors.